Jane Street Group, LLC Cue Biopharma, Inc. Transaction History
Jane Street Group, LLC
- $444 Billion
- Q4 2024
A detailed history of Jane Street Group, LLC transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 63,767 shares of CUE stock, worth $76,520. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,767
Previous 25,935
145.87%
Holding current value
$76,520
Previous $19,000
242.11%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CUE
# of Institutions
57Shares Held
11.9MCall Options Held
22KPut Options Held
1.2K-
Bleichroeder LP New York, NY5MShares$6 Million1.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$2.47 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$908,0830.0% of portfolio
-
Geode Capital Management, LLC Boston, MA631KShares$757,5370.0% of portfolio
-
Robertson Stephens Wealth Management, LLC San Francisco, CA479KShares$574,2000.02% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $42.5M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...